Wall Street analysts expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to announce $158.98 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Sabra Health Care REIT’s earnings, with the highest sales estimate coming in at $163.41 million and the lowest estimate coming in at $154.03 million. Sabra Health Care REIT reported sales of $166.47 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 4.5%. The company is scheduled to issue its next earnings results on Wednesday, February 20th.
On average, analysts expect that Sabra Health Care REIT will report full-year sales of $649.57 million for the current financial year, with estimates ranging from $639.46 million to $659.07 million. For the next fiscal year, analysts anticipate that the company will post sales of $658.59 million, with estimates ranging from $645.70 million to $667.97 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Sabra Health Care REIT.
Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Monday, November 5th. The real estate investment trust reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.42). The firm had revenue of $151.80 million during the quarter, compared to analyst estimates of $162.64 million. Sabra Health Care REIT had a return on equity of 11.80% and a net margin of 61.85%.
SBRA has been the topic of a number of research reports. ValuEngine upgraded Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Tuesday, October 9th. BidaskClub upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating in a report on Saturday, August 18th. Zacks Investment Research cut Sabra Health Care REIT from a “hold” rating to a “sell” rating in a report on Saturday, October 13th. BMO Capital Markets initiated coverage on Sabra Health Care REIT in a report on Tuesday, September 18th. They issued a “market perform” rating and a $24.00 price target on the stock. Finally, Jefferies Financial Group restated a “$21.91” rating and issued a $22.00 price target on shares of Sabra Health Care REIT in a report on Wednesday, July 18th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $22.73.
A number of hedge funds have recently bought and sold shares of SBRA. Royal Bank of Canada lifted its stake in Sabra Health Care REIT by 14.8% in the 1st quarter. Royal Bank of Canada now owns 166,361 shares of the real estate investment trust’s stock valued at $2,937,000 after buying an additional 21,434 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Sabra Health Care REIT by 2.7% in the 1st quarter. Principal Financial Group Inc. now owns 783,727 shares of the real estate investment trust’s stock valued at $13,833,000 after buying an additional 20,435 shares in the last quarter. Raymond James Trust N.A. lifted its stake in Sabra Health Care REIT by 29.0% in the 2nd quarter. Raymond James Trust N.A. now owns 19,219 shares of the real estate investment trust’s stock valued at $417,000 after buying an additional 4,318 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in shares of Sabra Health Care REIT by 120.7% during the 2nd quarter. Nisa Investment Advisors LLC now owns 142,798 shares of the real estate investment trust’s stock worth $3,103,000 after purchasing an additional 78,096 shares during the period. Finally, Goodwin Daniel L purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter worth $207,000. 90.72% of the stock is currently owned by hedge funds and other institutional investors.
Shares of SBRA traded down $0.11 on Monday, reaching $21.28. The stock had a trading volume of 2,300,951 shares, compared to its average volume of 1,912,372. The stock has a market cap of $3.87 billion, a P/E ratio of 8.76, a P/E/G ratio of 2.78 and a beta of 0.56. The company has a debt-to-equity ratio of 1.00, a current ratio of 2.88 and a quick ratio of 3.16. Sabra Health Care REIT has a twelve month low of $15.77 and a twelve month high of $23.83.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 30th. Investors of record on Thursday, November 15th will be paid a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 8.46%. The ex-dividend date is Wednesday, November 14th. Sabra Health Care REIT’s payout ratio is currently 74.07%.
Sabra Health Care REIT Company Profile
As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.
Featured Story: What is a Leveraged Buyout (LBO)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.